AI governance isn’t nested boxes or monthly committees. It’s architecture. Under HIPAA and GDPR, your “data steward” often can’t even review the data. Real governance is built into the plumbing, validation, lineage, and security enforced automatically. Otherwise, it’s theater.
Healthcare is rapidly adopting Customer Data Platforms to unify patient data and personalize engagement. Used as infrastructure, CDPs improve identity resolution, consent management, and outreach. But without clear governance, they risk optimizing for engagement over clinical need.
Digital twins are moving from factories to hospitals. We’re building replicas of patients, modeling disease in real time, and of physicians, capturing decades of expertise. The twin extends capacity while preserving oversight. What will happen when they no longer need us in between?
A 57-year-old liver transplant patient arrives confused and lethargic, with asterixis and ascites. No experienced clinician makes a diagnosis from one signal, a single heart rate, a single lab, a single image. But much of healthcare AI is still built that way. The clinical reality is multimodal.
In healthcare AI we focus on algorithms, models, accuracy. The quieter question: whose data can the AI actually see? The answer has less to do with the model and more to do with how you receive care. Your insurance type may determine whether your care is AI-ready at all.
AI won’t replace physicians, but it will redefine them. As knowledge shifts from memory to machine, the xPhysician emerges: an AI-augmented generalist who combines deep expertise with end-to-end ownership, reshaping how medicine is practiced and learned.
“AI in healthcare” is no longer a category, it’s a confusion. We treat mature, low-risk systems the same as experimental, high-risk ones. The real issue isn’t AI itself, it’s matching governance to actual risk and use.